Related Experiment Video
Updated: May 17, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Risk of cardiovascular events associated with positive serology for Chagas: a systematic review
Bruno Linetzky1, Jonatan Konfino, Noelia Castellana
1Fundación ECLA, Rosario, Argentina. brunolinetzky@yahoo.com.ar
Insights
Positive Chagas serology increases death risk in heart failure patients. However, evidence linking Chagas serology to cardiovascular events in asymptomatic individuals is limited.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Chagas disease disproportionately affects impoverished populations in Latin America.
- This review examines the association between Chagas serology and cardiovascular event risk.
Purpose of the Study:
- To assess the independent risk of cardiovascular events in individuals with positive Chagas serology.
- To synthesize evidence from existing studies on Chagas disease and cardiovascular outcomes.
Main Methods:
- A systematic literature search was conducted on Medline, Lilacs, and Embase databases.
- Studies included were those comparing Chagas-positive individuals with a control group and a follow-up exceeding one year.
- Outcomes of interest included death, stroke, heart failure, and left ventricular dysfunction.
Main Results:
- Twenty-five studies met the inclusion criteria.
- Positive Chagas serology was associated with an increased risk of death in patients with heart failure (functional class III/IV) and those with mild symptoms.
- Limited evidence suggests a higher mortality risk in asymptomatic individuals with positive Chagas serology, particularly in older cohorts.
Conclusions:
- Positive Chagas serology is linked to elevated mortality risk in heart failure patients.
- There is insufficient evidence to establish a clear link between positive Chagas serology and cardiovascular events in asymptomatic subjects.
Background:
Chagas disease affects mainly poor populations in Latin America. This review assesses the evidence on the independent risk of cardiovascular events associated with positive Chagas serology.
Methods:
We searched for studies using the following outcomes: death, stroke, new onset heart failure, heart failure hospitalization or evidence of left ventricular dysfunction. Studies comparing patients with positive serology for Chagas with a control group with a follow-up longer than 1 year were selected. The Medline, Lilacs and Embase databases were searched on 21 January 2011 without restrictions.
Results:
From 5236 potentially relevant studies, 25 fulfilled the inclusion criteria. Fourteen included patients with heart failure, six with severe symptoms and nine with mild symptoms or asymptomatic patients with low ejection fraction. In four studies of patients in functional class III or IV and in three studies of patients with mild symptoms, a higher risk of death was reported among those with positive serology for Chagas. Of the 11 studies of patients without symptoms or low ejection fraction, 3 showed a higher risk of mortality related to Chagas exposure. Two of these were based on the same cohort of people aged >60 years. Overall, 8 out of the 14 heart failure studies and 2 out of the 11 heart damage studies adjusted for confounding factors.
Conclusion:
Positive serology for Chagas is associated with a higher risk of death for patients with heart failure. However, there is little evidence to link positive serology for Chagas with cardiovascular events in asymptomatic subjects.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis I: Introduction
Endocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
